Voyager Therapeutics (NASDAQ: VYGR) SVP files Form 3 with no shares

Rhea-AI Filing Summary

Voyager Therapeutics, Inc. officer Gregory L. Shiferman filed an initial ownership report on Form 3 stating that, as of 01/06/2026, he beneficially owns no securities of the company. He is identified as Senior Vice President and General Counsel, and the filing is made by a single reporting person.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Shiferman Gregory L.

(Last) (First) (Middle)

C/O VOYAGER THERAPEUTICS, INC.

75 HAYDEN AVENUE

(Street)

LEXINGTON MA 02421

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/06/2026

3. Issuer Name and Ticker or Trading Symbol
Voyager Therapeutics, Inc. [ VYGR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and General Counsel

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1: Limited Power of Attorney

No securities are beneficially owned.

	/s/ Gregory L. Shiferman	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 3 for Voyager Therapeutics (VYGR)?

The Form 3 was filed by Gregory L. Shiferman, who is listed as Senior Vice President and General Counsel of Voyager Therapeutics, Inc..

What does this Voyager Therapeutics (VYGR) Form 3 disclose about ownership?

The filing states in the remarks that no securities are beneficially owned by the reporting person.

What is Gregory L. Shiferman’s role at Voyager Therapeutics (VYGR)?

Gregory L. Shiferman is identified as an officer of Voyager Therapeutics, serving as SVP and General Counsel.

Is this Voyager Therapeutics (VYGR) Form 3 filed by more than one reporting person?

No. The Form 3 checkbox shows it is filed by one reporting person, not a group.

What is the event date reported in this Voyager Therapeutics (VYGR) Form 3?

The date of event requiring the statement is listed as 01/06/2026.

Does the Form 3 include any derivative or non-derivative securities tables for Voyager Therapeutics (VYGR)?

The standard table headings appear, but the remarks clarify that no securities are beneficially owned, and no holdings are reported.